The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product…
Active Awarded Last action
- Contract number
- 75N93021D00015
- Awardee
-
Rutgers, The State University UEI QHHJD3X516J9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $10,535 obligated
Award facts
- Opportunity
-
- Preclinical Services for HIV Therapeutics Pre-Solicitation · 75N93019R00021 · Posted Oct 4, 2019
- Preclinical Services for HIV Therapeutics Solicitation · Posted Dec 5, 2019
- Combined order value
- $10,535 Current and potential, with all options
- Last date to order 86% complete
- IDV ceiling <1% used
- $107,274,471.00
- Maximum order
- $107,274,471.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery contract to Rutgers, The State University on October 15, 2020, with a ceiling of $107.274 million and ultimate completion date of October 14, 2027. This is one of multiple awards under the Preclinical Services for HIV Therapeutics program.
The contractor shall provide preclinical development support for candidate products and drug development activities ranging from initial product discovery through activities required to support clinical trials and product licensure. Work encompasses seven task areas: in vitro testing, synthesis of therapeutic agents, small animal models for HIV/HBV/HCV and mycobacterium, formulation development and clinical dosage manufacturing, preclinical pharmacology and toxicology, and a reagent program for HIV and other infectious diseases. Place of performance is Newark, New Jersey.
Task Area B for synthesis of therapeutic agents carries a small business set-aside under NAICS 541715 (research and development in the physical, engineering, and life sciences, excluding nanotechnology and biotechnology research and development) with a 1,000 employee size standard. The solicitation anticipated 6–21 task orders issued annually across the seven task areas, valued at approximately $500,000 to $5 million each.
Recent delivery orders under this IDIQ include a $10,535.37 task order awarded April 15, 2021, for development and delivery of a quality assurance/quality control plan and participation in task order initiation meeting, with completion August 14, 2021. A guaranteed minimum task order was issued on the contract award date, October 15, 2020, with completion May 25, 2021.
Description
The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product discovery to those required to support clinical trials and/o
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93021D00015?
75N93021D00015 was awarded to Rutgers, The State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 15, 2020.
How much is contract 75N93021D00015 worth?
Orders under 75N93021D00015 have obligated $10,535. 75N93021D00015's own ceiling is $107,274,471. A single order can be worth up to $107,274,471.
How many orders have been placed under contract 75N93021D00015?
2 orders have been placed under 75N93021D00015, the latest on April 15, 2021.
Who can order from contract 75N93021D00015?
75N93021D00015 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93021D00015 part of a contract vehicle?
Yes. 75N93021D00015 is part of Preclinical Services for HIV Therapeutics.
Was contract 75N93021D00015 competed?
The extent of competition for 75N93021D00015 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV